Company: IXHL
Filing Date: 2025-04-28
Form Type: 424B3
Source: 0001213900-25-036065
Chunk: 36

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-28
Form: 424B3
Chunk 36
---
 possible acquisitions
and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in our control
and may adversely affect the market price of the Common Stock and the voting and other rights of the holders of Common Stock. We have
no current plans to issue any shares of preferred stock.

Prior to the issuance of shares
of each series, the board of directors is required by the DGCL and our Certificate of Incorporation to adopt resolutions and file a certificate
of designation with the Secretary of State of the State of Delaware. The certificate of designation fixes for each class or series the
designations, powers, preferences, rights, qualifications, limitations and restrictions, including dividend rights, conversion rights,
redemption privileges and liquidation preferences.

Warrants

As of April 11, 2025, (i)
1,978,338shares of our Common Stock were issuable upon exercise of outstanding common stock
warrants to purchase Common Stock with a weighted average exercise price of $20.04per share,
(ii) 2,925,794shares of our Common Stock were issuable upon exercise of outstanding common
stock warrants to purchase Common Stock with a weighted average exercise price of $0.0001per
share and (ii) 347,222,700 shares of our Common Stock would be issuable upon exercise of outstanding Series A Warrants to purchase Common
Stock, assuming full adjustment of the exercise price per share from $2.16 to the Floor Price and exercise by way of the zero exercise
price provisions of the Series A Warrants following and assuming the Stockholder Approval.

Registration Rights

On October 31, 2024, pursuant
to that certain Securities Purchase Agreement (the “ELOC Purchase Agreement”), dated September 6, 2024, by and between us
and Arena Business Solutions Global SPC II, Ltd (“Arena Global”), we issued a warrant (the “ELOC Warrant”) to
purchase up to 585,000 shares of Common Stock to Arena Global as a commitment fee pursuant to the ELOC Purchase Agreement. On March 10,
2025, the exercise price of the ELOC Warrant was reset to the par value of our Common Stock, which is $0.0001 per share. The number of
warrant shares underlying the ELOC Warrant remain unchanged.

On October 11, 2024, pursuant
to that certain Securities Purchase Agreement, dated September 6, 2024 (the “